Key facts
- Rivio (Enterprise Systems (Healthcare))’s last known valuation is $93.0M (Dec 2025).
- It has raised $18.6M; the latest was Early Stage VC ($18.6M) in Dec 2025.
- Notable investors include Valor Capital Group, Monashees, Catarinense Technology Association, Endeavor Promessas.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Rivio (Enterprise Systems (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Rivio (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rivio (Enterprise Systems (Healthcare))
Developer of an AI-powered financial management platform designed to help healthcare organizations. The company's platform offers features such as AI-reviewed medical bills, audit, automatic XML submission, financial control, enabling hospitals to manage bureaucratic processes, piles of paperwork, and administrative disputes in a simplified way.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2025
- Employees
- 42
- Website
- rivio.com.br/
- Ownership
- Privately Held (backing)
Rivio (Enterprise Systems (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rivio (Enterprise Systems (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rivio (Enterprise Systems (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.